Cary J. Claiborne - Dec 7, 2021 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Operating Officer, Director
Signature
/s/ Cary J. Claiborne
Stock symbol
ADIL
Transactions as of
Dec 7, 2021
Transactions value $
$0
Form type
4
Date filed
12/8/2021, 08:23 PM
Previous filing
Nov 3, 2021
Next filing
Feb 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock options Award $0 +130K $0.00 130K Dec 7, 2021 Common stock 130K $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months.